Phase 2 studies

by Statistical Consultancy Team

March 5, 2024

A Guide to Integrated Summaries of Safety & Effectiveness (ISS & ISE)

This guide demonstrates how to plan, review, produce successful integrated summaries of safety and effectiveness (ISS & ISE) for regulatory submissions

Read more

by Clinical Programming Team

February 4, 2019

The Advantages of Parallel Processing Clinical Data in SAS/Connect

This blog post reviews the Advantages of Parallel Processing on the reporting and analysis of clinical trial data using SAS/Connect. Learn more with Quanticate's programming experts.

Read more

by Statistical Consultancy Team

November 29, 2018

Re-Randomization Tests in Equivalence Trials: Can We Still Use Them?

This blog post reviews re-randomization tests in equivalence trials and superiority trials and if, when and how to use them.

Read more

by Statistical Consultancy Team

October 29, 2018

FDA Guidance for Human Gene Therapy for Hemophilia A & B

This blog post reviews the FDA's guidance for Human Gene Therapy (GT) for Hemophilia A & B clinical trials and what is needed to support an accelerated approval approach. Learn More

Read more

by Thomas Underwood

August 16, 2016

The Rise of Risk Based Monitoring [Infographic]

This infographic presents survey data that indicates the increase in the use of risk-based monitoring and how data from trials using RBM solutions has risen

Read more

by Thomas Underwood

April 26, 2016

The Rise of Risk-Based Monitoring in Clinical Trials

This Quanticate blog post examines the rise of Risk Based Monitoring in clinical trials and growing trends from industry data in the adoption of RBM

Read more

by Medical Writing Team

April 15, 2016

The Different Phases of Clinical Trials

Quanticate blogs on the different phases of clinical trials that are classified into 4 phases, with each potentially lasting for several years.

Read more